Abstract: 【Abstract】Anemia is a common complication among chronic kidney disease patients, which affects health and quality of life of the patients, and imposes a tremendous economic burden for patients and society. Currently, the compliance rate of renal anemia is unsatisfactory. Accurate evaluation of the target of renal anemia treatment, rational and effective use of anti-anemia drugs, and development of economical and effective new anti-anemia drugs are essential in clinical practice. Treatment of renal anemia can be of great significance to reduce the burden of patients and society, improve the quality of life in CKD patients, delay the disease progression, and improve the clinical prognosis.

Key words: Renal anemia, Chronic kidney disease, Burden